Nov. Rally In Biotech With Small Caps Taking Off

The market pivoted upwards in November as investors looked ahead to 2021 with expectations that COVID-19 vaccines would temper the pandemic. Vaccine stock leaders took off again with BioNTech and Moderna up 30% in one week at new highs.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.